Oligomerix Company
Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Bronx, New York, United States
Founded Date:
2006
Employees Number:
1-10
Estimated Revenue:
$1M to $10M
Register and Claim Ownership